174 related articles for article (PubMed ID: 37371989)
1. Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia.
Li J; Li D; Guo J; Wang D; Zhang X
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371989
[TBL] [Abstract][Full Text] [Related]
2. Association of negative symptoms with cognitive impairment in Chinese Han patients with chronic schizophrenia.
Zhu R; Wang D; Wei G; Wang J; Zhou H; Xu H; Wang W; Wei S; Chen D; Xiu M; Wang L; Zhang XY
Int J Psychiatry Clin Pract; 2021 Sep; 25(3):292-298. PubMed ID: 33879034
[TBL] [Abstract][Full Text] [Related]
3. The relationship between cognitive impairment and superoxide dismutase activity in untreated first-episode patients with schizophrenia.
Wang DM; Du YX; Zhu RR; Tian Y; Chen JJ; Chen DC; Wang L; Zhang XY
World J Biol Psychiatry; 2022 Sep; 23(7):517-524. PubMed ID: 34918615
[No Abstract] [Full Text] [Related]
4. Plasma total antioxidant status and cognitive impairments in schizophrenia.
Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
[TBL] [Abstract][Full Text] [Related]
5. Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits.
Huo L; Lu X; Wu F; Chang C; Ning Y; Zhang XY
BMC Psychiatry; 2021 Dec; 21(1):606. PubMed ID: 34863137
[TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
[TBL] [Abstract][Full Text] [Related]
7. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia.
Zhang W; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
Schizophr Res; 2023 May; 255():140-147. PubMed ID: 36989671
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
Zhang XY; Chen DC; Xiu MH; Yang FD; Tan YL; He S; Kosten TA; Kosten TR
Schizophr Res; 2013 Feb; 143(2-3):301-6. PubMed ID: 23238053
[TBL] [Abstract][Full Text] [Related]
9. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
[TBL] [Abstract][Full Text] [Related]
10. Cognitive Impairment and Psychopathology Are Related to Plasma Oxidative Stress in Long Term Hospitalized Patients With Chronic Schizophrenia.
Yang M; Li J; Yang H; Yan L; Liu D; Zhu L; Zhang X
Front Psychiatry; 2022; 13():896694. PubMed ID: 35757215
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls.
Zhang XY; Tang W; Xiu MH; Chen DC; Yang FD; Tan YL; Wang ZR; Zhang F; Liu J; Liu L; Chen Y; Wen N; Kosten TR
Brain Behav Immun; 2013 Aug; 32():105-11. PubMed ID: 23499732
[TBL] [Abstract][Full Text] [Related]
12. Sex difference in association between insomnia and cognitive impairment in patients with chronic schizophrenia.
Zhu R; Wang D; Tian Y; Du Y; Chen J; Zhou H; Chen D; Wang L; Alonzo BA; Emily Wu H; Yang Zhang X
Schizophr Res; 2022 Feb; 240():143-149. PubMed ID: 35026599
[TBL] [Abstract][Full Text] [Related]
13. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia.
Wei CW; Chen YQ; Ma M; Xiu MH; Zhang XY
Transl Psychiatry; 2020 Jan; 10(1):18. PubMed ID: 32066717
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study.
Zhang XY; Chen DC; Xiu MH; Haile CN; Sun H; Lu L; Kosten TA; Kosten TR
PLoS One; 2012; 7(5):e36563. PubMed ID: 22570726
[TBL] [Abstract][Full Text] [Related]
16. Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia.
Huo L; Zheng Z; Lu X; Wu F; Ning Y; Zhang XY
Front Psychiatry; 2021; 12():641278. PubMed ID: 34239458
[No Abstract] [Full Text] [Related]
17. Sex-specific association between peripheral superoxide dismutase, BDNF and cognitive impairment in drug-naive first episode patients with schizophrenia.
Qu M; Wang J; Chen DC; Chen S; Xiu MH; Zhang XY
Free Radic Biol Med; 2020 Nov; 160():887-893. PubMed ID: 32949664
[TBL] [Abstract][Full Text] [Related]
18. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
[TBL] [Abstract][Full Text] [Related]
19. BDNF affects the mediating effect of negative symptoms on the relationship between age of onset and cognition in patients with chronic schizophrenia.
Xu H; Wang J; Zhou Y; Chen D; Xiu M; Wang L; Zhang X
Psychoneuroendocrinology; 2021 Mar; 125():105121. PubMed ID: 33387927
[TBL] [Abstract][Full Text] [Related]
20. Association of cognitive and P50 suppression deficits in chronic patients with schizophrenia.
Xia L; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Zhang G; Du X; Jia Q; Zhu X; Wang L; Tang W; Zhang XY
Clin Neurophysiol; 2020 Mar; 131(3):725-733. PubMed ID: 32000073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
